1. |
Waters RE 2nd, Singh KP, Roe MT, et al. Rationale and strategies for implementing community-based transfer protocols for primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. J Am Coll Cardiology, 2004, 43(12):2153-2159.
|
2. |
Bainey KR, Armstrong PW. Clinical perspectives on reperfusion injury in acute myocardial infarction. Am Heart J, 2014, 167(5):637-645.
|
3. |
Garciarena CD, Fantinelli JC, Caldiz CI, et al. Myocardial reperfusion injury:reactive oxygen species vs NHE-1 reactivation. Cell Physiol Biochem, 2011, 27(1):13-22.
|
4. |
Ma HJ, Li Q, Ma HJ, et al. Chronic intermittent hypobaric hypoxia ameliorate ischemia/reperfusion-induced calcium overload in heart via Na/Ca Exchanger in developing Rats. Cell Physiol Biochem, 2014, 34(2):313-324.
|
5. |
Xu T, Wu X, Chen Q, et al. The anti-apoptotic and cardioprotective effects of salvianolic acid A on rat cardiomyocytes following ischemia/reperfusion by DUSP-mediated regulation of the ERK1/2/JNK pathway. PloS One, 2014, 9(7):e102292.
|
6. |
Carswell EA, Old LJ, Kassel RL, et al. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA, 1975, 72(9):3666-3670.
|
7. |
Çekiç C, Aslan F, Vatansever S, et al. Latent tuberculosis screening tests and active tuberculosis infection rates in Turkish inflammatory bowel disease patients under anti-tumor necrosis factor therapy. Ann Gastroenterol, 2015,28(2):241-246.
|
8. |
Dinh W, Futh R, Nickl W, et al. Elevated plasma levels of TNF-alpha and interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders. Cardiovasc Diabetol, 2009, 8(2):58.
|
9. |
Ridker PM, Luscher TF. Anti-inflammatory therapies for cardiovascular disease. Eur Heart J, 2014, 35(27):1782-1791.
|
10. |
何金波, 包财盈, 叶玉柱, 等. 缺氧/复氧大鼠心肌中IL-1β浓度的动态变化及意义. 中国应用生理学杂志,2015, 1:27-30.
|
11. |
Ao L, Zou N, Cleveland JC, et al. Myocardial TLR4 is a determinant of neutrophil infiltration after global myocardial ischemia:mediating KC and MCP-1 expression induced by extracellular HSC70. Am J Physiol Heart Circ Physiol, 2009, 297(1):H21-H28.
|
12. |
高思海, 肖诗亮, 杨辰垣. 三甲氧苄嗪对大鼠离体心脏再灌注损伤的保护作用.中国胸心血管外科临床杂志, 2002, 9(3):192-194.
|
13. |
Zhang C, Huang Y, Zhang Q-Z, et al. Effect of bushen gujin recipe on serum and synovia interleukin-1 and tumor necrosis factor-alpha of knee osteoarthritis model rabbits. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2015, 35(3):355-358.
|
14. |
Cheng JZ, Yu D, Zhang H, et al. Inhibitive effect of IL-24 gene on CD133(+) laryngeal cancer cells. Asian Pac J Trop Med, 2014, 7(11):867-872.
|
15. |
Golia E, Limongelli G, Natale F, et al. Inflammation and cardiovascular disease:from pathogenesis to therapeutic target. Curr Atheroscler Rep, 2014, 16(9):435.
|
16. |
Brown WV, Remaley AT, Ridker PM. JCL Roundtable:Is inflammation a future target in preventing arteriosclerotic cardiovascular disease. J Clin Lipidol, 2015, 9(2):119-128.
|
17. |
Rodrigues FL, Fais RS, Tostes RC, et al. There is a link between erectile dysfunction and heart failure:It could be inflammation. Curr Drug Targets, 2015, 16(5):442-450.
|
18. |
Bironaite D, Daunoravicius D, Bogomolovas J, et al. Molecular mechanisms behind progressing chronic inflammatory dilated cardiomyopathy. BMC Cardiovasc Disord, 2015, 15(1):26.
|
19. |
Zwerina J, Redlich K, Polzer K, et al. TNF-induced structural joint damage is mediated by IL-1. Proc Natl Acad Sci USA, 2007, 104(28):11742-11747.
|
20. |
Kang MW, Song HJ, Kang SK, et al. Nafamostat mesilate inhibits TNF-α-induced vascular endothelial cell dysfunction by inhibiting reactive oxygen species production. Korean J Physiol Pharmacol, 2015, 19(3):229-234.
|
21. |
Hayslip J, Dressler EV, Weiss H, et al. Plasma TNF-α and soluble TNF receptor levels after doxorubicin with or without Co-administration of mesna——A randomized, cross-over clinical study. PloS One, 2015, 10(4):e0124988.
|
22. |
Wangensteen KJ, Zhang S, Greenbaum LE, et al. A genetic screen reveals Foxa3 and TNFR1 as key regulators of liver repopulation. Genes Dev, 2015, 29(9):904-909.
|
23. |
Cabal-Hierro L, Lazo PS. Signal transduction by tumor necrosis factor receptors. Cell signal, 2012, 24(6):1297-1305.
|
24. |
Fragoso Lona JM, Sierra Martinez M, Vargas Alarcon G, et al. Tumor necrosis factor alfa in cardiovascular diseases:molecular biology and genetics. Gac Med Mex, 2013, 149(5):521-530.
|
25. |
Levine B, Kalman J, Mayer L, et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med, 1990, 323(4):236-241.
|
26. |
Cugno M, Ingegnoli F, Gualtierotti R, et al. Potential effect of anti-tumour necrosis factor-alpha treatment on reducing the cardiovascular risk related to rheumatoid arthritis. Curr Vasc Pharmacol, 2010, 8(2):285-292.
|